Why the study?
Does hyperinsulinemia prevent the adverse effects of hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight/obese nondiabetic humans?
Does hyperinsulinemia prevent the adverse effects of hyperglycemia on vascular inflammatory biomarkers and endothelial function in overweight/obese nondiabetic humans?
In overweight and obese nondiabetic individuals, moderate hyperglycemia acutely impairs endothelial function and increases proinflammatory markers, but these effects are prevented by concomitant hyperinsulinemia.
Answers are grounded in this paper and cite their sources.
Hyperinsulinemia may blunt acute hyperglycemic endothelial impairment in obesity; leaves open relevance to chronic vascular risk.
We investigated the separate and combined effects of hyperglycemia and hyperinsulinemia on markers of endothelial function, proinflammatory and proatherothrombotic responses in overweight/obese nondiabetic humans. Twenty-two individuals (13 F/9 M, BMI 30.1 ± 4.1 kg/m(2)) were studied during four randomized, single-blind protocols. The pancreatic clamp technique was combined with 4-h glucose clamps consisting of either 1) euinsulinemia-euglycemia, 2) euinsulinemia-hyperglycemia, 3) hyperinsulinemia-hyperglycemia, or 4) hyperinsulinemia-euglycemia. Insulin levels were higher (998 ± 66 vs. 194 ± 22 pmol/l) during hyperinsulinemia compared with euinsulinemia. Glucose levels were 11.1 mmol/l during hyperinsulinemia compared with 5.1 ± 0.1 mmol/l during euglycemia. VCAM, ICAM, P-selectin, E-selectin, IL-6, adiponectin, and PAI-1 responses were all increased (P < 0.01-0.0001), and endothelial function was decreased (P < 0.0005) during euinsulinemia-hyperglycemia compared with other protocols. Hyperinsulinemia in the presence of hyperglycemia prevented the increase in proinflammatory and proatherothrombotic markers while also normalizing vascular endothelial function. We conclude that 4 h of moderate hyperglycemia can result in increases of proinflammatory markers (ICAM, VCAM, IL-6, E-selectin), platelet activation (P-selectin), reduced fibrinolytic balance (increased PAI-1), and disordered endothelial function in a group of obese and overweight individuals. Hyperinsulinemia prevents the actions of moderate hyperglycemia to reduce endothelial function and increase proinflammatory and proatherothrombotic markers.
No takes yet. Share an insight, caveat, or question.
Perkins et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: